{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:25:43Z","timestamp":1790821543284,"version":"4.1.0"},"reference-count":6,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2026,5,1]]},"abstract":"<jats:p>This case series describes 6 cases of interstitial lung disease among patients with multiple sclerosis receiving long-term treatment with ocrelizumab.<\/jats:p>","DOI":"10.1001\/jamaneurol.2026.0548","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T15:00:47Z","timestamp":1775487647000},"page":"505","source":"Crossref","is-referenced-by-count":4,"title":["Interstitial Lung Disease as a Late Occurrence in Ocrelizumab-Treated Patients With Multiple Sclerosis"],"prefix":"10.1001","volume":"83","author":[{"given":"Anna E.","family":"Zurawska","sequence":"first","affiliation":[{"name":"Center of Neurology, Lodz, Poland"},{"name":"Department of Neurology and Neurosurgery, University of Warmia and Mazury, Olsztyn, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne H.","family":"Cross","sequence":"additional","affiliation":[{"name":"Department of Neurology, Washington University School of Medicine, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Rzeszutek","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, Center for Pulmonary Disorder Treatment, Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Rogozi\u0144ska-Zawi\u015blak","sequence":"additional","affiliation":[{"name":"Department of Radiology, Center for Pulmonary Disorder Treatment, Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof W.","family":"Selmaj","sequence":"additional","affiliation":[{"name":"Center of Neurology, Lodz, Poland"},{"name":"Department of Neurology and Neurosurgery, University of Warmia and Mazury, Olsztyn, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"nld260002r1","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa1601277","article-title":"Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis.","volume":"376","author":"Hauser","year":"2017","journal-title":"N Engl J Med"},{"key":"nld260002r2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2023.578066","article-title":"Predictors of hypogammaglobulinemia and serious infections among patients receiving ocrelizumab or rituximab for treatment of MS and NMOSD.","volume":"377","author":"Mears","year":"2023","journal-title":"J Neuroimmunol"},{"issue":"14","key":"nld260002r3","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1177\/13524585241297038","article-title":"Secondary organising pneumonia associated to COVID-19 infection in patients with central nervous system inflammatory demyelinating diseases treated with anti-CD20 therapies.","volume":"30","author":"Carvajal","year":"2024","journal-title":"Mult Scler"},{"issue":"11","key":"nld260002r4","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1056\/NEJMra2116777","article-title":"Cryptogenic organizing pneumonia.","volume":"386","author":"King","year":"2022","journal-title":"N Engl J Med"},{"issue":"6","key":"nld260002r5","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1177\/13524585241295677","article-title":"Ocrelizumab-associated cryptogenic organizing pneumonia in multiple sclerosis: two case reports and comprehensive literature review.","volume":"31","author":"Gans","year":"2025","journal-title":"Mult Scler"},{"key":"nld260002r6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1190235","article-title":"Diagnostic testing for interstitial lung disease in common variable immunodeficiency: a systematic review.","volume":"14","author":"Bintalib","year":"2023","journal-title":"Front Immunol"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2847194\/jamaneurology_zurawska_2026_ld_260002_1778071474.81384.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T15:00:23Z","timestamp":1778511623000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2847194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":6,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2026.0548","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,1]]}}}